LLY

761.21

-0.27%↓

JNJ

174.07

-1.65%↓

ABBV

221.11

+0.52%↑

UNH

335.52

-1.53%↓

AZN

76.8

-0.93%↓

LLY

761.21

-0.27%↓

JNJ

174.07

-1.65%↓

ABBV

221.11

+0.52%↑

UNH

335.52

-1.53%↓

AZN

76.8

-0.93%↓

LLY

761.21

-0.27%↓

JNJ

174.07

-1.65%↓

ABBV

221.11

+0.52%↑

UNH

335.52

-1.53%↓

AZN

76.8

-0.93%↓

LLY

761.21

-0.27%↓

JNJ

174.07

-1.65%↓

ABBV

221.11

+0.52%↑

UNH

335.52

-1.53%↓

AZN

76.8

-0.93%↓

LLY

761.21

-0.27%↓

JNJ

174.07

-1.65%↓

ABBV

221.11

+0.52%↑

UNH

335.52

-1.53%↓

AZN

76.8

-0.93%↓

Search

DexCom Inc

Aperta

SettoreSettore sanitario

75.56 -0.89

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

72.1

Massimo

76.39

Metriche Chiave

By Trading Economics

Entrata

74M

180M

Vendite

121M

1.2B

P/E

Media del settore

53.603

35.293

EPS

0.32

Margine di Profitto

15.539

Dipendenti

10,200

EBITDA

90M

309M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+31.8% upside

Dividendi

By Dow Jones

Utili prossimi

23 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-5.2B

30B

Apertura precedente

76.45

Chiusura precedente

75.56

Notizie sul Sentiment di mercato

By Acuity

50%

50%

167 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

DexCom Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 lug 2025, 18:41 UTC

Acquisizioni, Fusioni, Takeovers

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

25 ott 2024, 09:10 UTC

Utili

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

Confronto tra pari

Modifica del prezzo

DexCom Inc Previsione

Obiettivo di Prezzo

By TipRanks

31.8% in crescita

Previsioni per 12 mesi

Media 100.89 USD  31.8%

Alto 112 USD

Basso 89 USD

Basato su 22 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per DexCom Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

22 ratings

18

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

71.66 / N/ASupporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Neutral Evidence

Sentiment

By Acuity

167 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
help-icon Live chat